IGFL1

IGF like family member 1 Q6UW32 IGFL1_HUMAN
Protein Coding Chr 19 19q13.32 Swiss-Prot reviewed Entrez 374918
Mutations
59
CL 11 · Tissue 47
Samples
59
CL 11 · Tissue 47
Peptides
43
unique mutant peptides
Transcripts
1
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations591147
Samples591147
Peptides43638

Function

IGFL1 · IGF like family member 1

The protein encoded by this gene is a member of the insulin-like growth factor family of signaling molecules. The encoded protein is synthesized as a precursor protein and is proteolytically cleaved to form a secreted mature peptide. The mature peptide binds to a receptor, which in mouse was found on the cell surface of T cells. Increased expression of this gene may be linked to psoriasis. [provided by RefSeq, Aug 2016].

Isoforms & Proteins

1 transcript · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000437936 Q6UW32 59 43

Gene Properties

Type
Protein Coding
Chromosome
19
Cytoband
19q13.32
Entrez ID
Aliases
APRG644UNQ644

Recurrent Mutations

All 43 amino-acid changes on canonical ENST00000437936 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in IGFL1 · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in IGFL1 – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
T-Lymphoblastic Leukemia
1/40 2%
0/0 0%
Glioblastoma
2/98 2%
0/0 0%
Melanoma
4/210 2%
10/1899 1%
Endometrial Carcinoma
0/42 0%
2/612 0%
Bladder Carcinoma
0/58 0%
3/956 0%
Non-Small Cell Lung Carcinoma
0/304 0%
5/1390 0%
Colorectal Carcinoma
0/143 0%
9/3239 0%
Other Sarcomas
2/69 3%
0/699 0%
Hepatocellular Carcinoma
0/46 0%
3/2210 0%
Other Solid Cancers
0/94 0%
2/1515 0%
Non-Cancerous
0/104 0%
1/830 0%
Gastric Carcinoma
0/74 0%
2/1809 0%
Other Blood Cancers
0/61 0%
3/2725 0%
Biliary Tract Carcinoma
0/54 0%
1/950 0%
Breast Carcinoma
0/144 0%
3/3264 0%
Esophageal Squamous Cell Carcinoma
2/51 4%
0/2550 0%
B-Lymphoblastic Leukemia
0/55 0%
2/2640 0%
Kidney Carcinoma
0/85 0%
1/1862 0%
Glioma
0/52 0%
1/2127 0%

Mutation Distribution

Where IGFL1 is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in IGFL1 were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

GTEx Expression

Median TPM across 15 healthy tissues

GTEx Portal ↗
About the expression data
GTEx Expression

Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.

Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.

Scroll or drag the mini-axis below the chart to browse all tissues.

Mutations

All 59 mutations in IGFL1

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide